An observational study in Shock, sponsored by Hennepin Healthcare Research Institute. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-10-24.
Sponsored by Hennepin Healthcare Research Institute · Observational
Currently, bedside ultrasound (US) is performed routinely in emergency department (ED) patients with undifferentiated shock to help guide resuscitation. Previously, it has never been possible to measure cardiac output on patients in the ED. Our clinical question looks at whether the USCOM device gives clinically relevant information in addition to ED cardiac US in patients with shock.
916 studies on the registry are indexed under Shock; 176 are open to participants now.
This study's enrollment of 47 is below the median of 91 across 346 observational studies indexed under Shock.
Browse Shock studies →Hennepin Healthcare Research Institute is the lead sponsor of 69 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients presenting to the emergency department at an urban county hospital.
Exclusion Criteria:
Defined by systolic blood pressure less than 95 mmHg or shock index (heart rate/systolic blood pressure) greater than 0.9
Device: USCOM
The USCOM device will be used in addition to cardiac ultrasound in patients with shock.
Cardiac Output
Cardiac ultrasound findings will be compared to cardiac index and output from the USCOM device
Time frame: Twice during ED visit, averaging one hour
Patient outcomes
Data will be collected on outcomes of patients including death, length of ICU stay, length of hospital stay, and diagnosis.
Time frame: After emergency department visit
This study is completed, as verified in Oct 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hennepin Healthcare Research Institute